Status:

COMPLETED

An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)

Lead Sponsor:

Ortho Biotech Products, L.P.

Conditions:

Anemia

HIV Infections

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

The objective of this study was to treat anemic (Hemoglobin (Hb) \< 12 g/dL) HIV-infected subjects with once weekly (QW) PROCRIT (Epoetin alfa) to a target Hb of \> 13 g/dL and then to assess if the t...

Detailed Description

This was a Phase IV, open-label, non-randomized, multi-center study conducted in community based practices, physicians networks, or academic institutions in the US. This study included anemic (Hb \< 1...

Eligibility Criteria

Inclusion

  • Understand and sign written informed consent
  • HIV-infected patients (as documented by HIV-RNA values)
  • HIV/HCV co-infected patients not receiving treatment
  • Hemoglobin \< 12 g/dL unrelated to transfusion
  • Estimated life expectancy of \> 9 months
  • Has been maintained on a stable antiretroviral regimen for at least four weeks prior to enrollment into this study.

Exclusion

  • Acute, symptomatic opportunistic infection or other acute AIDS defining illness
  • Anemia attributable to factors other than HIV infection (i.e., iron, B12 or folate deficiencies, hemolysis, gastrointestinal bleeding)
  • HCV co-infected patients who are anticipated to receive treatment with ribavirin/interferon during the study period. Previous treatment with ribavirin/interferon must have been completed at least 12 weeks prior to study entry
  • Ferritin level \< 40 ng/mL
  • Uncontrolled or severe cardiovascular disease including recent (\< 6 months) myocardial infarction, uncontrolled hypertension or congestive heart failure

Key Trial Info

Start Date :

October 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2004

Estimated Enrollment :

292 Patients enrolled

Trial Details

Trial ID

NCT00317902

Start Date

October 1 2002

End Date

May 1 2004

Last Update

May 19 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.